Mandate

VINGE ADVISES SWEGON

July 10, 2014

Vinge has advised Swegon in connection with the acquisition of 90 per cent of the shares in the Belgian airflow technology company P. Lemmens from the current shareholders Waterland Private Equity and Stephan Lemmens. P. Lemmens has 59 employees and had a turnover of EUR 26 million in 2013. P. Lemmens largest product segment is total airflow control within an integrated electronic control system. The other product segments include fans, ventilation and heat recovery products.

Swegon is part of the Latour Group and is a market leading producer and supplier of energy efficient ventilation and climate systems. Swegon has 1 650 employees and a turnover of SEK 3.3 billion.

Vinge’s team consisted of partner Magnus Pauli and associate Daniel Lennartsson.

Related

Vinge advises Aspo on its acquisition of Swed Handling

Vinge advises Aspo, listed on Nasdaq Helsinki, in the transaction whereby Aspo's subsidiary Telko expands its chemicals business in Sweden by acquiring Swed Handling, a leading Swedish chemical distributor, from TeRa Invest. As part of the transaction, Aspo’s subsidiary Leipurin expands its food industry business in Sweden, via the technical food ingredient distributor Kebelco, which is a subsidiary of Swed Handling. The closing of the transaction is subject to customary regulatory approvals.
April 30, 2024

Vinge advises on the sale of Vinnergi Holding AB

Vinge has advised Sobro and other shareholders in connection with the sale of Vinnergi Holding AB to Polaris, a Nordic investment firm. In connection with the transaction, the management and employees are reinvesting a significant portion to further develop the company. The Vinnergi Group conducts operations in technology consulting and software development in Sweden, with a particular focus on telecoms, energy and real estate.
April 30, 2024

Vinge has advised Pareto Securities in connection with a rights issue in Episurf Medical

Vinge has advised Pareto Securities in connection with a partially secured rights issue of units of up to approximately SEK 120 million in Episurf Medical.
April 24, 2024